Analysts' Viewpoints: AstraZeneca (AZN), Banco Bilbao Vizcaya Argentaria (BBVA), Alaska Air Group (ALK), Masco (MAS), Amazon (AMZN)
Shares of AstraZeneca plc (NYSE:AZN) were initiated with an Overweight rating by analysts at Piper Jaffray
AstraZeneca, a biopharmaceutical company, focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in various therapy areas, including respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology, as well as in infection, neuroscience and gastrointestinal areas.
Equities researchers at Jefferies started coverage on Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) shares with a Buy rating
Banco Bilbao Vizcaya Argentaria is a diversified international financial company engaged in retail banking, asset management, private banking and wholesale banking.
Brokerage firm Imperial Capital initiated coverage on Alaska Air Group, Inc. (NYSE:ALK) stock with an In-line rating and a price target of $74.00
Alaska Air Group is the holding company of Alaska Airlines and Horizon Air.
BofA/Merrill Lynch has resumed coverage on shares of Masco Corp. (NYSE:MAS) with a Buy rating and a price objective on $41.00
Masco designs, manufactures, markets and distributes branded home improvement and building products.
Investment analysts at Mizuho boosted their price target on Amazon.com, Inc. (Nasdaq:AMZN) stock from $855.00 to $950.00, while maintaining a Buy rating
Amazon.com, Inc. offers a range of products and services through its Websites. Its products include merchandise and content that it purchases for resale from vendors and those offered by third-party sellers.
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWEWorld Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at www.crweworld.com/finance_disclaimer